Research study Program year 2022 Source: CMS Open Payments

Lung Oncology Clinical Publication Program

Research payments

$43,310

29 payments

Through program year 2022, $43,310 in research payments was reported against Lung Oncology Clinical Publication Program, across 29 payments, paid by Pfizer Inc..

Paid by: Pfizer Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$27,540	16
2021	Research	$15,770	13

Breakdown

Who paid Research payments · program years 2021–2022

Pfizer Inc. $43,310 29 payments

Who received the money Research payments · program years 2021–2022

Todd Bauer Hematology & Oncology · Nashville, TN $10,670 8 payments
Alice Shaw Internal Medicine · Boston, MA $10,470 6 payments
Sai Hong Ou Hematology & Oncology · Orange, CA $6,400 2 payments
Anne Tsao Medical Oncology · Houston, TX $3,530 2 payments
Suresh Ramalingam Medical Oncology · Atlanta, GA $3,530 2 payments
Gregory Riely Medical Oncology · New York, NY $3,530 2 payments
Bruce Johnson Medical Oncology · Boston, MA $3,530 2 payments
Maen Hussein Medical Oncology · Tavares, FL $330 1 payment
Melissa Johnson Medical Oncology · Nashville, TN $330 1 payment
Ibiayi Dagogo-Jack Internal Medicine · Boston, MA $330 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.